Menu

SAB Biotherapeutics, Inc. SABS

Full chart Compare
Set alert

Price alert · SABS

All alert types
3.03 USD +0.09 (+3.06%)

At closeNov 6, 2026, 4:01 PM EST

3.03 0.00 0.00%

After hours · Nov 6, 4:01 PM ET

2.91 Day range 3.14
2.49 52-week range 4.59
YTD
-18.98%
1 year
-2.26%

Revenue & Expenses

Other Income → Expenses: $8.81MExpenses → Gross Loss: $3.47MExpenses → Selling, General & Admin: $9.28MExpenses → Research & Development: $30.16MNet Loss → Expenses: $34.11MRevenue → Cost of Revenue: $1.32MOther Income$8.81MNet Loss$34.11MCost of Revenue$4.79MExpenses$42.91MGross Loss$3.47MSelling, General & Admin$9.28MResearch & Development$30.16MRevenue$1.32M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

SABS annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
48.95M44.23M40.31M52.82M74.27M
34.35M30.25M16.52M36.44M57.18M
14.60M13.98M23.80M16.38M17.09M
-48.95M-42.91M-38.08M-28.92M-13.39M
240.66K318.40K315.28K301.58K294.46K
13.27M-34.11M-42.19M-18.74M-17.14M
13.27M-34.11M-42.19M-18.74M-17.14M
13.27M-34.11M-42.19M-18.74M-17.14M
13.27M-34.11M-42.19M-18.74M-17.14M
0.22-3.68-7.64-4.31-6.30
0.22-3.68-7.64-4.31-6.30
-0.79-3.68-7.64-4.31-6.30
13.51M-33.79M-41.88M-18.41M-16.85M
13.51M-33.79M-41.88M-18.41M-16.85M
19.31M9.26M5.52M4.35M2.73M
61.34M9.26M5.52M4.35M2.73M